NYVEPRIA: Package Insert and Label Information (Page 3 of 3)
PRINCIPAL DISPLAY PANEL — 6 mg/0.6 mL Syringe Label
Nyvepria™
(pegfilgrastim-apgf) Injection
Rx only
6 mg/0.6 mL
For Subcutaneous Use Only
Single-Dose Prefilled Syringe
with Needle Guard
NDC 0069-0324-01
Mfd by Hospira, Inc., a Pfizer
Company Lake Forest, IL 60045 USAUS License No. 1974
PAA147907
PRINCIPAL DISPLAY PANEL — 6 mg/0.6 mL Syringe Carton — PAA185776
Nyvepria™
(pegfilgrastim-apgf) Injection
6 mg/0.6 mL
For Subcutaneous Use Only
Sterile Solution — No Preservative
1 x 6 mg/0.6 mL
Single-Dose Prefilled Syringe
with Needle Guard
Pegylated Recombinant Methionyl Human
Granulocyte Colony-Stimulating Factor(PEG-r-metHuG-CSF) derived from E coli
NDC 0069-0324-01
Rx Only
PRINCIPAL DISPLAY PANEL — 6 mg/0.6 mL Syringe Carton — PAA185777
Nyvepria™
(pegfilgrastim-apgf) Injection
6 mg/0.6 mL
For Subcutaneous Use Only
Sterile Solution — No Preservative
1 x 6 mg/0.6 mL Single-Dose
Prefilled Syringe with Needle Guard
Pegylated Recombinant Methionyl Human
Granulocyte Colony-Stimulating Factor(PEG-r-metHuG-CSF) derived from E coli
NDC 0069-0324-01
Rx Only
NYVEPRIA pegfilgrastim-apgf injection, solution | |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
Labeler — Pfizer Laboratories Div Pfizer Inc (134489525) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Hospira Zagreb d.o.o. | 500625201 | ANALYSIS (0069-0324), MANUFACTURE (0069-0324), API MANUFACTURE (0069-0324), PACK (0069-0324), LABEL (0069-0324) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Pfizer Inc | 004954111 | ANALYSIS (0069-0324) |
Revised: 03/2023 Pfizer Laboratories Div Pfizer Inc
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.